Literature DB >> 29863758

Membrane rafts-redox signalling pathway contributes to renal fibrosis via modulation of the renal tubular epithelial-mesenchymal transition.

Wei-Qing Han1,2,3, Lian Xu1,2, Xiao-Feng Tang1,3, Wen-Dong Chen1,3, Yong-Jie Wu1,3, Ping-Jin Gao1,2,3.   

Abstract

KEY POINTS: Membrane rafts (MRs)-redox signalling pathway is activated in response to transforming growth factor-β1 (TGF-β1) stimulation in renal tubular cells. This pathway contributes to TGF-1β-induced epithelial-mesenchymal transition (EMT) in renal tubular cells. The the MRs-redox signalling pathway is activated in renal tubular cells isolated from angiotensin II (AngII)-induced hypertensive rats. Inhibition of this pathway attenuated renal inflammation and fibrosis in AngII-induced hypertension. ABSTRACT: The membrane rafts (MRs)-redox pathway is characterized by NADPH oxidase subunit clustering and activation through lysosome fusion, V-type proton ATPase subunit E2 (encoded by the Atp6v1e2 gene) translocation and sphingomyelin phosphodiesterase 1 (SMPD1, encoded by the SMPD1 gene) activation. In the present study, we hypothesized that the MRs-redox-derived reactive oxygen species (ROS) are involved in renal inflammation and fibrosis by promoting renal tubular epithelial-mesenchymal transition (EMT). Results show that transforming growth factor-β1 (TGF-β1) acutely induced MR formation and ROS production in NRK-52E cells, a rat renal tubular cell line. In addition, transfection of Atp6v1e2 small hairpin RNAs (shRNA) and SMPD1 shRNA attenuated TGF-β1-induced changes in EMT markers, including E-cadherin, α-smooth muscle actin (α-SMA) and fibroblast-specific protein-1 (FSP-1) in NRK-52E cells. Moreover, Erk1/2 activation may be a downstream regulator of the MRs-redox-derived ROS, because both shRNAs significantly inhibited TGF-β1-induced Erk1/2 phosphorylation. Further in vivo study shows that the renal tubular the MRs-redox signalling pathway was activated in angiotensin II (AngII)-induced hypertension, as indicated by the increased NADPH oxidase subunit Nox4 fraction in the MR domain, SMPD1 activation and increased ROS content in isolated renal tubular cells. Finally, renal transfection of Atp6v1e2 shRNA and SMPD1 shRNA significantly prevented renal fibrosis and inflammation, as indicated by the decrease of α-SMA, fibronectin, collagen I, monocyte chemoattractant protein-1 (MCP-1), intercellular cell adhesion molecule-1 (ICAM-1) and tumour necrosis factor-α (TNF-α) in kidneys from AngII-infused rats. It was concluded that the the MRs-redox signalling pathway is involved in TGF-β1-induced renal tubular EMT and renal inflammation/fibrosis in AngII-induced hypertension.
© 2018 The Authors. The Journal of Physiology © 2018 The Physiological Society.

Entities:  

Keywords:  angiotensin II; epithelial-mesenchymal transition; membrane rafts; renal fibrosis

Mesh:

Substances:

Year:  2018        PMID: 29863758      PMCID: PMC6092309          DOI: 10.1113/JP275952

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  59 in total

1.  Inhibitory effect of statins on renal epithelial-to-mesenchymal transition.

Authors:  Sharmila Patel; Roger M Mason; Jun Suzuki; Atsushi Imaizumi; Takashi Kamimura; Zhi Zhang
Journal:  Am J Nephrol       Date:  2006-07-26       Impact factor: 3.754

2.  Contributory role of endothelium and voltage-gated potassium channels in apocynin-induced vasorelaxations.

Authors:  Wei-qing Han; Wing Tak Wong; Xiao Yu Tian; Yu Huang; Ling-yun Wu; Ding-liang Zhu; Ping-jin Gao
Journal:  J Hypertens       Date:  2010-10       Impact factor: 4.844

3.  Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation.

Authors:  M Zeisberg; G Bonner; Y Maeshima; P Colorado; G A Müller; F Strutz; R Kalluri
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

4.  NADPH oxidase-dependent formation of reactive oxygen species contributes to transforming growth factor β1-induced epithelial-mesenchymal transition in rat peritoneal mesothelial cells, and the role of astragalus intervention.

Authors:  Xiao-xian Liu; Hong-juan Zhou; Long Cai; Wen Zhang; Ji-lin Ma; Xiao-juan Tao; Jian-ning Yu
Journal:  Chin J Integr Med       Date:  2012-10-22       Impact factor: 1.978

Review 5.  SNARE proteins and 'membrane rafts'.

Authors:  Thorsten Lang
Journal:  J Physiol       Date:  2007-05-03       Impact factor: 5.182

6.  Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis.

Authors:  Marialuisa Bocchino; Savina Agnese; Evelina Fagone; Silvia Svegliati; Domenico Grieco; Carlo Vancheri; Armando Gabrielli; Alessandro Sanduzzi; Enrico V Avvedimento
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

Review 7.  ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy.

Authors:  Jian-Mei Li; Ajay M Shah
Journal:  J Am Soc Nephrol       Date:  2003-08       Impact factor: 10.121

8.  Amitriptyline attenuates interstitial inflammation and ameliorates the progression of renal fibrosis.

Authors:  Eduardo Achar; Thiago T Maciel; Carlos F Collares; Vicente P C Teixeira; Nestor Schor
Journal:  Kidney Int       Date:  2008-11-26       Impact factor: 10.612

9.  Nox4 Plays a Role in TGF-β-Dependent Lens Epithelial to Mesenchymal Transition.

Authors:  Shannon J Das; Frank J Lovicu; Emma J Collinson
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-07-01       Impact factor: 4.799

10.  Role of Nox4 in murine models of kidney disease.

Authors:  Andrea Babelova; Despina Avaniadi; Oliver Jung; Christian Fork; Janet Beckmann; Judith Kosowski; Norbert Weissmann; Narayana Anilkumar; Ajay M Shah; Liliana Schaefer; Katrin Schröder; Ralf P Brandes
Journal:  Free Radic Biol Med       Date:  2012-06-27       Impact factor: 7.376

View more
  9 in total

1.  Membrane raft redox signalling contributes to renal tubular cell epithelial-mesenchymal transition and fibrosis and inflammation of the kidneys.

Authors:  Haisam Shah; Alison Hacker
Journal:  J Physiol       Date:  2018-08-19       Impact factor: 5.182

2.  The potential role of complement alternative pathway activation in hypertensive renal damage.

Authors:  Chongjian Wang; Zhiyu Wang; Wen Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-27

3.  Baicalin reversal of DNA hypermethylation-associated Klotho suppression ameliorates renal injury in type 1 diabetic mouse model.

Authors:  Xiao-Tan Zhang; Guang Wang; Liu-Fang Ye; Yu Pu; Run-Tong Li; Jianxin Liang; Lijun Wang; Kenneth Ka Ho Lee; Xuesong Yang
Journal:  Cell Cycle       Date:  2020-11-16       Impact factor: 4.534

4.  Renal tubular epithelial cells: the neglected mediator of tubulointerstitial fibrosis after injury.

Authors:  Ruochen Qi; Cheng Yang
Journal:  Cell Death Dis       Date:  2018-11-13       Impact factor: 8.469

5.  SIRT3 Deficiency Sensitizes Angiotensin-II-Induced Renal Fibrosis.

Authors:  Xiaomeng Feng; Han Su; Xiaochen He; Jian-Xiong Chen; Heng Zeng
Journal:  Cells       Date:  2020-11-20       Impact factor: 6.600

6.  Mechanism of herbal medicine on hypertensive nephropathy (Review).

Authors:  Zhaocheng Dong; Haoran Dai; Zhandong Feng; Wenbin Liu; Yu Gao; Fei Liu; Zihan Zhang; Na Zhang; Xuan Dong; Qihan Zhao; Xiaoshan Zhou; Jieli Du; Baoli Liu
Journal:  Mol Med Rep       Date:  2021-02-04       Impact factor: 2.952

7.  Protective Effects of Astragalus Polysaccharide on Sepsis-Induced Acute Kidney Injury.

Authors:  Jie Sun; Shanzhai Wei; Yilai Zhang; Jia Li
Journal:  Anal Cell Pathol (Amst)       Date:  2021-01-26       Impact factor: 2.916

8.  NOX2 Is Critical to Endocardial to Mesenchymal Transition and Heart Development.

Authors:  Hoda Moazzen; Yan Wu; Anish Engineer; Xiangru Lu; Simran Aulakh; Qingping Feng
Journal:  Oxid Med Cell Longev       Date:  2020-06-16       Impact factor: 6.543

Review 9.  Crosstalk Between Acid Sphingomyelinase and Inflammasome Signaling and Their Emerging Roles in Tissue Injury and Fibrosis.

Authors:  Cao Li; Shanshan Guo; Wenyuan Pang; Zhigang Zhao
Journal:  Front Cell Dev Biol       Date:  2020-01-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.